Showing results (201-210 of 226) with videos related to
Sort By:
Pageof 23
Journal of Medicinal Chemistry|June 1, 1988
Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralinC Mellin, L Björk, A Karlén, et al.Journal of Medicinal Chemistry|August 1, 1982
Monophenolic octahydrobenzo[f]quinolines: central dopamine- and serotonin-receptor stimulating activityH Wikström, D Sanchez, P Lindberg, et al.Life Sciences|January 1, 1995
The design and pharmacology of novel selective muscarinic agonists and antagonistsG Lambrecht, J Gross, U Hacksell, et al.Psychopharmacology|January 1, 1983
Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPPS Hjorth, A Carlsson, D Clark, et al.Journal of Medicinal Chemistry|October 1, 1987
C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptorsA M Johansson, J L Nilsson, A Karlén, et al.The Journal of Comparative Neurology|July 1, 1986
Cytoarchitecture, fiber connections, and some histochemical aspects of the interpeduncular nucleus in the ratH J Groenewegen, S Ahlenius, S N Haber, et al.Journal of Medicinal Chemistry|February 1, 1991
A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralinC Mellin, J Vallgårda, D L Nelson, et al.Journal of Medicinal Chemistry|April 1, 1981
Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activityU Hacksell, L E Arvidsson, U Svensson, et al.Journal of Medicinal Chemistry|August 1, 1985
Novel dopamine receptor agonists and antagonists with preferential action on autoreceptorsA M Johansson, L E Arvidsson, U Hacksell, et al.Journal of Medicinal Chemistry|January 1, 1984
8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonistsL E Arvidsson, U Hacksell, A M Johansson, et al.Pageof 23